SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-4.27%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$501M
AUM Growth
+$501M
(+27%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
29.64%
Top 10 Holdings %
Top 10 Hldgs %
32.77%
Holding
285
New
86
Increased
57
Reduced
47
Closed
30
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$35.7M |
| 2 |
Biogen
BIIB
|
$22.9M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$18.3M |
| 4 |
Viatris
VTRS
|
$15.2M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$14.5M |
Top Sells
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$28.9M |
| 2 |
Merck
MRK
|
$17.9M |
| 3 |
Exxon Mobil
XOM
|
$14.8M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$10M |
| 5 |
Gevo
GEVO
|
$7.38M |
Sector Composition
| 1 | Healthcare | 64.78% |
| 2 | Energy | 5.21% |
| 3 | Technology | 2.24% |
| 4 | Materials | 2.17% |
| 5 | Consumer Discretionary | 0.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Adverum Biotechnologies
ADVM
$68.2M
| $4.73M | 0.2% |
57,426
+37,646
| +190% | +$3.1M |
|
|
DERM
27
DELISTED
Dermira, Inc.
DERM
| $4.44M | 0.18% |
190,000
-86,994
| -31% | -$2.03M |
|
28
Gilead Sciences
GILD
$140B
| $4.43M | 0.18% |
+45,140
| New | +$4.43M |
|
29
Arbutus Biopharma
ABUS
$753M
| $4.42M | 0.18% |
725,007
+419,656
| +137% | +$2.56M |
|
30
Inovio Pharmaceuticals
INO
$144M
| $4.26M | 0.18% |
61,463
-14,037
| -19% | -$974K |
|
31
Heron Therapeutics
HRTX
$204M
| $3.91M | 0.16% |
+160,323
| New | +$3.91M |
|
32
Cidara Therapeutics
CDTX
$1.61B
| $3.89M | 0.16% |
15,302
+553
| +4% | +$141K |
|
33
Novavax
NVAX
$1.2B
| $3.73M | 0.15% |
+26,352
| New | +$3.73M |
|
|
ASXC
34
DELISTED
Asensus Surgical, Inc.
ASXC
| $3.6M | 0.15% |
122,394
-7,283
| -6% | -$214K |
|
|
NWBO
35
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
| $3.58M | 0.15% |
572,518
+244,118
| +74% | +$1.53M |
|
|
ENDP
36
DELISTED
Endo International plc
ENDP
| $3.51M | 0.14% |
50,658
+13,300
| +36% | +$922K |
|
37
Champion Homes, Inc.
SKY
$4.34B
| $3.45M | 0.14% |
+447,944
| New | +$3.45M |
|
38
Indaptus Therapeutics
INDP
$5.98M
| $3.44M | 0.14% |
+274
| New | +$3.44M |
|
39
Dynavax Technologies
DVAX
$1.19B
| $3.31M | 0.14% |
134,954
+64,954
| +93% | +$1.59M |
|
|
HZNP
40
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $3.26M | 0.13% |
+164,658
| New | +$3.26M |
|
41
Iovance Biotherapeutics
IOVA
$800M
| $3.24M | 0.13% |
561,894
+134,650
| +32% | +$776K |
|
|
AXN
42
DELISTED
Aoxing Pharmaceutical Company Inc.
AXN
| $3.16M | 0.13% |
+2,134,054
| New | +$3.16M |
|
43
Vertex Pharmaceuticals
VRTX
$102B
| $3.12M | 0.13% |
+30,000
| New | +$3.12M |
|
44
Benitec Biopharma
BNTC
$365M
| $3.11M | 0.13% |
+1,981
| New | +$3.11M |
|
45
Lexicon Pharmaceuticals
LXRX
$392M
| $2.81M | 0.12% |
261,595
-57,180
| -18% | -$614K |
|
46
Pluri
PLUR
$40.5M
| $2.68M | 0.11% |
18,430
-22,341
| -55% | -$3.25M |
|
|
MDGN.WS
47
DELISTED
MEDGENICS INC WT PUR COM EXP 03/31/16
MDGN.WS
| $2.54M | 0.1% |
1,453,640
+13,800
| +1% | +$24.2K |
|
48
Tempest Therapeutics
TPST
$46.6M
| $2.53M | 0.1% |
102
-19
| -16% | -$471K |
|
49
Sangamo Therapeutics
SGMO
$161M
| $2.46M | 0.1% |
435,225
+111,835
| +35% | +$631K |
|
50
Lipocine
LPCN
$15.7M
| $2.38M | 0.1% |
11,848
-30,799
| -72% | -$6.19M |
|